Diabetes, Vol 40, Issue 4 465-471, Copyright © 1991 by American Diabetes Association

ARTICLES

Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats

S Goldfarb, FN Ziyadeh, EF Kern and DA Simmons
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-6144.

Early functional disturbances in nerve, retina, and lens in diabetes mellitus appear to result from a common mechanism involving increased polyol-pathway activity with an associated effect on tissue myo-inositol metabolism. We tested the role of increased polyol-pathway activity in the early glomerular hemodynamic abnormalities in experimental diabetes in rats with dietary myo-inositol supplementation or the administration of sorbinil, an aldose reductase inhibitor. Each maneuver prevented the glomerular hyperfiltration of early streptozocin-induced diabetes and reversed the hyperfiltration of established diabetes of 10 days' duration. We also found that the abnormal response to captopril in diabetic rats was improved by dietary myo-inositol supplementation or sorbinil administration. Although nonhypotensive doses of captopril lowered glomerular filtration rate (GFR) in diabetic rats on a 0.01% myo-inositol diet, GFR increased substantially after captopril infusion in diabetic rats treated with sorbinil or myo-inositol supplementation. These data suggest that normalization of tissue myo-inositol metabolism restores normal responsiveness to angiotensin II; this may contribute to the reduction in GFR with the two experimental maneuvers. We also tested the interaction between polyol-pathway activation and high dietary protein intake. Aldose reductase inhibition and dietary myo-inositol supplementation had no effect on the component of increased GFR due to 50% dietary protein intake but specifically inhibited the hyperfiltration attributable to diabetes. These results suggest that hyperglycemia acts through increased polyol-pathway activity and its effects on tissue myo-inositol metabolism to play a fundamental role in the pathogenesis of the glomerular hyperfiltration characteristic of early diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Haneda, D. Koya, M. Isono, and R. Kikkawa Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1374 - 1382. [Full Text] [PDF]

				M. ISONO, M. C. I.-D. L. CRUZ, S. CHEN, S. W. HONG, and F. N. ZIYADEH Extracellular Signal-Regulated Kinase Mediates Stimulation of TGF-{beta}1 and Matrix by High Glucose in Mesangial Cells J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2222 - 2230. [Abstract] [Full Text]

				L. R. James, I. G. Fantus, H. Goldberg, H. Ly, and J. W. Scholey Overexpression of GFAT activates PAI-1 promoter in mesangial cells Am J Physiol Renal Physiol, October 1, 2000; 279(4): F718 - F727. [Abstract] [Full Text] [PDF]

				J. KAPOR-DREZGIC, X. ZHOU, T. BABAZONO, J. A. DLUGOSZ, T. HOHMAN, and C. WHITESIDE Effect of High Glucose on Mesangial Cell Protein Kinase C-{delta} and - is Polyol Pathway-Dependent J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1193 - 1203. [Abstract] [Full Text]

				F. N. Ziyadeh, B. B. Hoffman, D. C. Han, M. C. Iglesias-de la Cruz, S. W. Hong, M. Isono, S. Chen, T. A. McGowan, and K. Sharma Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice PNAS, July 5, 2000; 97(14): 8015 - 8020. [Abstract] [Full Text] [PDF]